nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—LBP—metabolic syndrome X	0.0335	0.0525	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—LBP—metabolic syndrome X	0.0261	0.041	CbGpPWpGaD
Imiquimod—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—EPHX2—metabolic syndrome X	0.0259	0.0405	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—LBP—metabolic syndrome X	0.0258	0.0405	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—LBP—metabolic syndrome X	0.0254	0.0398	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—LBP—metabolic syndrome X	0.0198	0.031	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—LBP—metabolic syndrome X	0.0196	0.0307	CbGpPWpGaD
Imiquimod—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.0173	0.0271	CbGpPWpGaD
Imiquimod—Fungal infection—Metformin—metabolic syndrome X	0.0162	0.0469	CcSEcCtD
Imiquimod—Rigors—Metformin—metabolic syndrome X	0.0154	0.0444	CcSEcCtD
Imiquimod—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.0153	0.0239	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CCL5—metabolic syndrome X	0.0141	0.0221	CbGpPWpGaD
Imiquimod—CYP1A2—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.0134	0.021	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CCL5—metabolic syndrome X	0.011	0.0173	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CCL5—metabolic syndrome X	0.0107	0.0168	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.0103	0.0162	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—CD36—metabolic syndrome X	0.0101	0.0159	CbGpPWpGaD
Imiquimod—Nasal congestion—Metformin—metabolic syndrome X	0.00999	0.0289	CcSEcCtD
Imiquimod—Injury—Metformin—metabolic syndrome X	0.0099	0.0286	CcSEcCtD
Imiquimod—Lethargy—Metformin—metabolic syndrome X	0.00929	0.0268	CcSEcCtD
Imiquimod—Pain in extremity—Metformin—metabolic syndrome X	0.0091	0.0263	CcSEcCtD
Imiquimod—Migraine—Metformin—metabolic syndrome X	0.00896	0.0259	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00841	0.0132	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—LBP—metabolic syndrome X	0.00837	0.0131	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CCL5—metabolic syndrome X	0.00835	0.0131	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.00827	0.013	CbGpPWpGaD
Imiquimod—Breast disorder—Metformin—metabolic syndrome X	0.00823	0.0238	CcSEcCtD
Imiquimod—Influenza—Metformin—metabolic syndrome X	0.00787	0.0227	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—CD36—metabolic syndrome X	0.00767	0.012	CbGpPWpGaD
Imiquimod—Sweating increased—Metformin—metabolic syndrome X	0.00766	0.0221	CcSEcCtD
Imiquimod—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.00766	0.012	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.00757	0.0119	CbGpPWpGaD
Imiquimod—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00731	0.0211	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—FGF21—metabolic syndrome X	0.00716	0.0112	CbGpPWpGaD
Imiquimod—Infestation NOS—Metformin—metabolic syndrome X	0.00702	0.0203	CcSEcCtD
Imiquimod—Infestation—Metformin—metabolic syndrome X	0.00702	0.0203	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PLA2G6—metabolic syndrome X	0.00689	0.0108	CbGpPWpGaD
Imiquimod—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00688	0.0199	CcSEcCtD
Imiquimod—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00664	0.0192	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00649	0.0102	CbGpPWpGaD
Imiquimod—TLR8—adipose tissue—metabolic syndrome X	0.00646	0.421	CbGeAlD
Imiquimod—TLR7—Innate Immune System—LBP—metabolic syndrome X	0.00635	0.00994	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TRIB3—metabolic syndrome X	0.00635	0.00994	CbGpPWpGaD
Imiquimod—Rhinitis—Metformin—metabolic syndrome X	0.00631	0.0182	CcSEcCtD
Imiquimod—Connective tissue disorder—Metformin—metabolic syndrome X	0.00619	0.0179	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00616	0.00965	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.00597	0.00935	CbGpPWpGaD
Imiquimod—Eye disorder—Metformin—metabolic syndrome X	0.00589	0.017	CcSEcCtD
Imiquimod—Flushing—Metformin—metabolic syndrome X	0.00585	0.0169	CcSEcCtD
Imiquimod—Angiopathy—Metformin—metabolic syndrome X	0.00571	0.0165	CcSEcCtD
Imiquimod—Immune system disorder—Metformin—metabolic syndrome X	0.00569	0.0164	CcSEcCtD
Imiquimod—Mediastinal disorder—Metformin—metabolic syndrome X	0.00568	0.0164	CcSEcCtD
Imiquimod—Chills—Metformin—metabolic syndrome X	0.00565	0.0163	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.00563	0.00882	CbGpPWpGaD
Imiquimod—Erythema—Metformin—metabolic syndrome X	0.00548	0.0158	CcSEcCtD
Imiquimod—Malnutrition—Metformin—metabolic syndrome X	0.00548	0.0158	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—metabolic syndrome X	0.00535	0.00839	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PLA2G6—metabolic syndrome X	0.00523	0.00819	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Metformin—metabolic syndrome X	0.00509	0.0147	CcSEcCtD
Imiquimod—CYP1A2—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00499	0.00782	CbGpPWpGaD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.00499	0.00781	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—metabolic syndrome X	0.00495	0.00776	CbGpPWpGaD
Imiquimod—Malaise—Metformin—metabolic syndrome X	0.00494	0.0143	CcSEcCtD
Imiquimod—Syncope—Metformin—metabolic syndrome X	0.00492	0.0142	CcSEcCtD
Imiquimod—TLR8—Immune System—LBP—metabolic syndrome X	0.00488	0.00764	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—metabolic syndrome X	0.00486	0.00762	CbGpPWpGaD
Imiquimod—Palpitations—Metformin—metabolic syndrome X	0.00485	0.014	CcSEcCtD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—PPARA—metabolic syndrome X	0.00484	0.00758	CbGpPWpGaD
Imiquimod—Loss of consciousness—Metformin—metabolic syndrome X	0.00482	0.0139	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TRIB3—metabolic syndrome X	0.00481	0.00753	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00475	0.00744	CbGpPWpGaD
Imiquimod—Hypertension—Metformin—metabolic syndrome X	0.00473	0.0137	CcSEcCtD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—metabolic syndrome X	0.00469	0.00735	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00469	0.00735	CbGpPWpGaD
Imiquimod—Myalgia—Metformin—metabolic syndrome X	0.00467	0.0135	CcSEcCtD
Imiquimod—Chest pain—Metformin—metabolic syndrome X	0.00467	0.0135	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00464	0.0134	CcSEcCtD
Imiquimod—Discomfort—Metformin—metabolic syndrome X	0.00461	0.0133	CcSEcCtD
Imiquimod—TLR8—liver—metabolic syndrome X	0.00453	0.296	CbGeAlD
Imiquimod—Oedema—Metformin—metabolic syndrome X	0.00447	0.0129	CcSEcCtD
Imiquimod—Infection—Metformin—metabolic syndrome X	0.00445	0.0128	CcSEcCtD
Imiquimod—Shock—Metformin—metabolic syndrome X	0.0044	0.0127	CcSEcCtD
Imiquimod—Nervous system disorder—Metformin—metabolic syndrome X	0.00439	0.0127	CcSEcCtD
Imiquimod—Skin disorder—Metformin—metabolic syndrome X	0.00435	0.0125	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.00435	0.00681	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Metformin—metabolic syndrome X	0.00433	0.0125	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—metabolic syndrome X	0.00432	0.00677	CbGpPWpGaD
Imiquimod—Anorexia—Metformin—metabolic syndrome X	0.00427	0.0123	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—metabolic syndrome X	0.00418	0.00655	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00408	0.0118	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—metabolic syndrome X	0.00406	0.00636	CbGpPWpGaD
Imiquimod—Paraesthesia—Metformin—metabolic syndrome X	0.00402	0.0116	CcSEcCtD
Imiquimod—TLR8—Immune System—PLA2G6—metabolic syndrome X	0.00402	0.00629	CbGpPWpGaD
Imiquimod—Dyspnoea—Metformin—metabolic syndrome X	0.00399	0.0115	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—AKT1—metabolic syndrome X	0.00399	0.00624	CbGpPWpGaD
Imiquimod—Somnolence—Metformin—metabolic syndrome X	0.00398	0.0115	CcSEcCtD
Imiquimod—Dyspepsia—Metformin—metabolic syndrome X	0.00394	0.0114	CcSEcCtD
Imiquimod—Decreased appetite—Metformin—metabolic syndrome X	0.00389	0.0112	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00386	0.0112	CcSEcCtD
Imiquimod—Fatigue—Metformin—metabolic syndrome X	0.00386	0.0111	CcSEcCtD
Imiquimod—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00385	0.00603	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—metabolic syndrome X	0.00375	0.00588	CbGpPWpGaD
Imiquimod—TLR7—Immune System—LBP—metabolic syndrome X	0.0037	0.00579	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TRIB3—metabolic syndrome X	0.0037	0.00579	CbGpPWpGaD
Imiquimod—Feeling abnormal—Metformin—metabolic syndrome X	0.00369	0.0106	CcSEcCtD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—metabolic syndrome X	0.00368	0.00577	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00366	0.0106	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00362	0.00567	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—metabolic syndrome X	0.00356	0.00557	CbGpPWpGaD
Imiquimod—Urticaria—Metformin—metabolic syndrome X	0.00355	0.0103	CcSEcCtD
Imiquimod—Abdominal pain—Metformin—metabolic syndrome X	0.00354	0.0102	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—metabolic syndrome X	0.00337	0.00528	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—metabolic syndrome X	0.00333	0.00522	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD36—metabolic syndrome X	0.00328	0.00514	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—metabolic syndrome X	0.00327	0.00513	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00323	0.00507	CbGpPWpGaD
Imiquimod—Asthenia—Metformin—metabolic syndrome X	0.00321	0.00927	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—metabolic syndrome X	0.00317	0.00496	CbGpPWpGaD
Imiquimod—Pruritus—Metformin—metabolic syndrome X	0.00317	0.00914	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT1—metabolic syndrome X	0.00311	0.00487	CbGpPWpGaD
Imiquimod—Diarrhoea—Metformin—metabolic syndrome X	0.00306	0.00884	CcSEcCtD
Imiquimod—TLR7—Immune System—PLA2G6—metabolic syndrome X	0.00304	0.00477	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT1—metabolic syndrome X	0.00302	0.00473	CbGpPWpGaD
Imiquimod—Dizziness—Metformin—metabolic syndrome X	0.00296	0.00854	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CRP—metabolic syndrome X	0.00296	0.00463	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CYBA—metabolic syndrome X	0.00286	0.00448	CbGpPWpGaD
Imiquimod—TLR7—liver—metabolic syndrome X	0.00286	0.186	CbGeAlD
Imiquimod—Vomiting—Metformin—metabolic syndrome X	0.00284	0.00821	CcSEcCtD
Imiquimod—Rash—Metformin—metabolic syndrome X	0.00282	0.00815	CcSEcCtD
Imiquimod—Dermatitis—Metformin—metabolic syndrome X	0.00282	0.00814	CcSEcCtD
Imiquimod—Headache—Metformin—metabolic syndrome X	0.0028	0.00809	CcSEcCtD
Imiquimod—TLR7—Immune System—TRIB3—metabolic syndrome X	0.0028	0.00439	CbGpPWpGaD
Imiquimod—Nausea—Metformin—metabolic syndrome X	0.00266	0.00767	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IRS1—metabolic syndrome X	0.00258	0.00404	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—metabolic syndrome X	0.00256	0.004	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—metabolic syndrome X	0.00253	0.00396	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.0025	0.00391	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—FMO3—metabolic syndrome X	0.00249	0.0039	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD36—metabolic syndrome X	0.00249	0.00389	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00246	0.00385	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—APOE—metabolic syndrome X	0.00242	0.00379	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—metabolic syndrome X	0.00236	0.00369	CbGpPWpGaD
Imiquimod—TLR8—Immune System—VCAM1—metabolic syndrome X	0.00232	0.00364	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.0023	0.0036	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00224	0.00351	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CRP—metabolic syndrome X	0.00224	0.00351	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00219	0.00343	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CYBA—metabolic syndrome X	0.00217	0.0034	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL18—metabolic syndrome X	0.00206	0.00322	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—LPL—metabolic syndrome X	0.00199	0.00312	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRS1—metabolic syndrome X	0.00196	0.00306	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.00192	0.00301	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD36—metabolic syndrome X	0.00191	0.00299	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.0019	0.00298	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.0019	0.00297	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CD36—metabolic syndrome X	0.00189	0.00297	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00185	0.0029	CbGpPWpGaD
Imiquimod—TLR7—Immune System—VCAM1—metabolic syndrome X	0.00176	0.00276	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00173	0.00271	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CRP—metabolic syndrome X	0.00172	0.0027	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00169	0.00265	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL18—metabolic syndrome X	0.00156	0.00244	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRS1—metabolic syndrome X	0.0015	0.00235	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GGT1—metabolic syndrome X	0.00146	0.00229	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD36—metabolic syndrome X	0.00145	0.00227	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00143	0.00224	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CRP—metabolic syndrome X	0.0013	0.00204	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—metabolic syndrome X	0.00114	0.00179	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRS1—metabolic syndrome X	0.00114	0.00178	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6—metabolic syndrome X	0.00108	0.00169	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.00107	0.00168	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AKT1—metabolic syndrome X	0.000996	0.00156	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GGT1—metabolic syndrome X	0.000856	0.00134	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000853	0.00134	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	0.000828	0.0013	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—metabolic syndrome X	0.000818	0.00128	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	0.000773	0.00121	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	0.000773	0.00121	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—metabolic syndrome X	0.000755	0.00118	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000682	0.00107	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000661	0.00104	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000646	0.00101	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—metabolic syndrome X	0.000629	0.000985	CbGpPWpGaD
Imiquimod—CYP3A4—kidney—metabolic syndrome X	0.000589	0.0384	CbGeAlD
Imiquimod—TLR8—Immune System—AKT1—metabolic syndrome X	0.00058	0.000909	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000562	0.000881	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.00055	0.000861	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000532	0.000834	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000527	0.000825	CbGpPWpGaD
Imiquimod—CYP1A2—liver—metabolic syndrome X	0.000514	0.0336	CbGeAlD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.00049	0.000767	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—metabolic syndrome X	0.000477	0.000747	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—metabolic syndrome X	0.00044	0.000689	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000437	0.000684	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000434	0.00068	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FMO3—metabolic syndrome X	0.000426	0.000668	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000421	0.00066	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000403	0.000632	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000392	0.000614	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000381	0.000597	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	0.00038	0.000595	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	0.00038	0.000595	CbGpPWpGaD
Imiquimod—CYP3A4—liver—metabolic syndrome X	0.000372	0.0243	CbGeAlD
Imiquimod—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	0.000357	0.000559	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.00034	0.000532	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000329	0.000515	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000329	0.000515	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FABP4—metabolic syndrome X	0.000304	0.000476	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000293	0.000459	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000293	0.000459	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	0.000288	0.000451	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000279	0.000437	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000276	0.000432	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000271	0.000425	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000266	0.000417	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—G6PD—metabolic syndrome X	0.000257	0.000402	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000253	0.000397	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	0.00025	0.000392	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPA—metabolic syndrome X	0.000245	0.000383	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCKR—metabolic syndrome X	0.000245	0.000383	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	0.000237	0.000371	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000235	0.000369	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA5—metabolic syndrome X	0.000235	0.000368	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000234	0.000367	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000228	0.000357	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000223	0.00035	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000222	0.000348	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000221	0.000346	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	0.000218	0.000342	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.000198	0.00031	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	0.000196	0.000307	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000195	0.000305	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LIPC—metabolic syndrome X	0.000194	0.000305	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCK—metabolic syndrome X	0.000194	0.000305	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000193	0.000303	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOC3—metabolic syndrome X	0.000193	0.000303	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCKR—metabolic syndrome X	0.000189	0.000296	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPA—metabolic syndrome X	0.000189	0.000296	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CETP—metabolic syndrome X	0.000188	0.000294	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	0.000183	0.000287	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA5—metabolic syndrome X	0.000181	0.000284	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	0.00018	0.000281	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000175	0.000274	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	0.000174	0.000273	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	0.00017	0.000266	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GOT2—metabolic syndrome X	0.00017	0.000266	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	0.000168	0.000264	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000153	0.00024	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	0.000151	0.000237	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	0.000151	0.000237	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	0.000151	0.000237	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LIPC—metabolic syndrome X	0.00015	0.000235	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCK—metabolic syndrome X	0.00015	0.000235	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOC3—metabolic syndrome X	0.000149	0.000234	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GOT1—metabolic syndrome X	0.000146	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GGT1—metabolic syndrome X	0.000146	0.000229	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CETP—metabolic syndrome X	0.000145	0.000227	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	0.000139	0.000217	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	0.000135	0.000211	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	0.000131	0.000205	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GOT2—metabolic syndrome X	0.000131	0.000205	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOB—metabolic syndrome X	0.000124	0.000195	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	0.000121	0.000189	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPL—metabolic syndrome X	0.000119	0.000186	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	0.000117	0.000183	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	0.000117	0.000183	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GGT1—metabolic syndrome X	0.000113	0.000177	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GOT1—metabolic syndrome X	0.000113	0.000177	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CD36—metabolic syndrome X	0.000113	0.000177	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARA—metabolic syndrome X	0.000105	0.000164	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AGT—metabolic syndrome X	0.000102	0.000159	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—metabolic syndrome X	9.95e-05	0.000156	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA1—metabolic syndrome X	9.83e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOB—metabolic syndrome X	9.59e-05	0.00015	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	9.33e-05	0.000146	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPL—metabolic syndrome X	9.16e-05	0.000143	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CD36—metabolic syndrome X	8.7e-05	0.000136	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—metabolic syndrome X	8.66e-05	0.000136	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INS—metabolic syndrome X	8.5e-05	0.000133	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARA—metabolic syndrome X	8.09e-05	0.000127	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AGT—metabolic syndrome X	7.83e-05	0.000123	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—metabolic syndrome X	7.79e-05	0.000122	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—metabolic syndrome X	7.68e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA1—metabolic syndrome X	7.59e-05	0.000119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—metabolic syndrome X	7.45e-05	0.000117	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	6.82e-05	0.000107	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—metabolic syndrome X	6.69e-05	0.000105	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INS—metabolic syndrome X	6.56e-05	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—metabolic syndrome X	6.01e-05	9.42e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—metabolic syndrome X	5.75e-05	9.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	5.26e-05	8.24e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—metabolic syndrome X	3.43e-05	5.37e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.64e-05	4.14e-05	CbGpPWpGaD
